Articles by Sonja Loges
Precision oncology without borders: the role of biobanking in integrating Africa’s genetic diversity into global genomic research
Abstract Cancer mortality in sub-Saharan Africa is projected to double by 2030. African populations exhibit the highest genetic diversity worldwide, impacting cancer susceptibility, tumor biology, and therapeutic response, yet remain critically underrepresented in biomedical research.
Embedding equity in Germany's National Lung Cancer Screening roll-out: a call to action
Get full text access Log in, subscribe or purchase for full access. References 1. Bray, F ∙ Laversanne, M ∙ Sung, H ∙ et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin. 2024; 74:229-263 2. de Koning, HJ ∙ van der Aalst, CM ∙ de Jong, PA ∙ et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial N Engl J Med. 2020; 382:503-513 3. Belachew, SA ∙ Bizuayehu, HM ∙ Diaz, A ∙ et al.
Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trial | Nature Communications
Abstract Beyond first line, the prognosis of relapsed/refractory (R/R) acute myeloid leukemia (AML) patients is poor with limited treatment options. Bemcentinib is an orally bioavailable, potent, highly selective inhibitor of AXL, a receptor tyrosine kinase associated with poor prognosis, chemotherapy resistance and decreased antitumor immune response.
The Role of TAM Receptors in Bone
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
IJMS | Free Full-Text | Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients
1. Introduction Liquid biopsy approaches using biological fluids for the detection of circulating tumor cells or tumor cell-derived genomic material (i.e., DNA or RNA) offer a suitable alternative to overcome the limitations of conventional tumor tissue-based diagnostics.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Sonja
Contact Sonja, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack